Posts by Paulo Bispo, PhD
-
Systematic Review: Multi-decade Antibiotic Resistance of Ocular Bacteria in the U.S.
Paulo Bispo, PhD, of Mass Eye and Ear, and colleagues found the ongoing ARMOR (Antibiotic Resistance Monitoring in Ocular micRoorganisms) U.S. surveillance study is representative of localized datasets, suggesting ARMOR findings can inform empiric therapy if local antibiotic susceptibility data aren't available.
Biography
Dr. Paulo Bispo is a microbiologist dedicated to developing better ways to diagnose, treat, and prevent infections. With training in innovation in clinical and molecular microbiology, his work is at the translational interface between laboratory research and clinical practice. His research focuses on the use of state-of-the-art molecular genetic and genomic approaches to develop new, rapid, sensitive, and comprehensive diagnostic tests. He is also using a combination of genomic and phenotypic approaches to study the epidemiology of antibiotic-resistant infections, biofilm-formation on artificial devices, and the development of novel approaches for prophylaxis and treatment of ocular and otolaryngology infections. He serves as an assistant director for the Harvard Ophthalmology Infectious Diseases Institute (IDI), and manager of the IDI’s Translational Research Initiative.
Mass Eye and Ear/Mass General Ophthalmology
An international center for ophthalmology treatment and research, Mass Eye and Ear/Massachusetts General Hospital is the primary teaching hospital of Harvard Medical School’s Department of Ophthalmology, and is consistently recognized as one of the nation’s top hospitals for eye care. Led by Chief and Chair Joan W. Miller, MD, the department provides seamless access to the most innovative care available anywhere in the world.
